Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIDS: Iron Repletion in Iron-Deficient Blood Donors
NCT02889133Completed
- Sponsor
- Columbia University
- Start
- Jan 2017
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of iron dextran in iron deficiency anemia (IDA) (2 arms), sponsored by Columbia University. Primary endpoint: 51-Chromium 24-hour Post-transfusion RBC Recovery of Units. Started Jan 2017; status: completed.
02
Drugs
iron dextran
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02889133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889133.